Abstract
To investigate possible relationships between genetic alterations and hormonal deregulation during breast cancer development and/or progression, we examined 616 primary breast cancers for loss of heterozygosity (LOH) at chromosomal regions 16q24, 17p13.3 and 17q21, and for amplifications of the ERBB2 and c-MYC loci. A comparison of oestrogen receptor (ER) and progesterone receptor (PgR) status in tumour cells with data concerning these genetic alterations revealed that LOH at 17q21 was significantly correlated with absence of oestrogen receptors (ER) (P < 0.0003) or progesterone receptors (PgR) (P < 0.0001), and with the absence of both (P < 0.0001). Similarly, a significant association was observed between amplification of ERBB2 and the absence of either ER or PgR. LOH at 17p13.3 was associated with the absence of PgR (P < 0.01). These data suggest a possible relationship between specific genetic changes on chromosome 17 and hormonal deregulation in the progression of breast cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ito, I., Yoshimoto, M., Iwase, T. et al. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer 71, 438–441 (1995). https://doi.org/10.1038/bjc.1995.89
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.89
This article is cited by
-
Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines
Cancer Cell International (2012)
-
C-myc as a predictive marker for chemotherapy in metastatic breast cancer
Clinical and Experimental Medicine (2012)
-
Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers
Breast Cancer (2002)
-
Identification of high-risk breast cancer patients from genetic changes of their tumors
Surgery Today (2000)
-
Overexpression of the Tpl-2/Cot oncogene in human breast cancer
Oncogene (1999)